ACTINIC KERATOSIS - SCORE (Step Therapy Criteria)
Customize your policy alerts
Sign up for all Blue Cross Blue Shield - South Carolina policy alerts
Know when Blue Cross Blue Shield - South Carolina releases new policies or updates existing guidance.
Monitor payer policy activity
This document lists step therapy requirements and affected products for several drug classes and specific medications for Blue Cross Blue Shield - South Carolina members. It governs prior authorization/step edits for drugs such as diclofenac gel, various antidepressants, atypical antipsychotics, Invega Hafyera, Relistor, and Rytary.
No material clinical or coverage changes in this revision.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.